MAP Pharmaceuticals (MAPP) to resume trading at 7:15AM ET
Tweet
Share
E-mailGet Alerts MAPP Hot Sheet
Join SI Premium – FREE
MAP Pharmaceuticals (Nasdaq: MAPP) to resume trading at 7:15AM ET after receiving FDA CRL for LEVADEX.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- NVIDIA (NVDA) in talks to invest in data-center company Cloverleaf Infrastructure - WSJ
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
Create E-mail Alert Related Categories
FDA, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
